FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Fate Therapeutics
Fate Therapeutics
Institut Paoli-Calmettes
OHSU Knight Cancer Institute
Fate Therapeutics
NKGen Biotech, Inc.
Orano Med LLC
Jonsson Comprehensive Cancer Center
ARCAGY/ GINECO GROUP